transferrin has been researched along with Follicular Thyroid Carcinoma in 8 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 7 (87.50) | 24.3611 |
| 2020's | 1 (12.50) | 2.80 |
| Authors | Studies |
|---|---|
| Akkielah, LA; Alguwaihes, A; Alhaddad, MA; Alhaddad, S; Alharbi, M; Alzahrani, S; Jammah, AA; Masood, A | 1 |
| Dehbi, HM; Hackshaw, A; Harmer, C; Mallick, U; Newbold, K; Wadsley, J | 1 |
| Bongaerts, AH; Coppes, MH; Glaudemans, AW; Links, TP; Wolffenbuttel, BH | 1 |
| Bardet, S; Blanchard, D; Ciappuccini, R; de Raucourt, D; Hardouin, J; Heutte, N; Quak, E; Rame, JP; Vaur, D | 1 |
| Dietlein, M; Dueren, C; Eichhorn, W; Grimm, J; Groth, P; Luster, M; Plenzig, F; Reiners, C; Steinke, R | 1 |
| Dietlein, M; Eschner, W; Kahraman, D; Kobe, C; Schmidt, M; Schneider, C | 1 |
| Chindris, AM; Crook, JE; Diehl, NN; Fatourechi, V; Smallridge, RC | 1 |
| Gerrard, G; Patel, CN; Prestwich, RJ; Scarsbrook, AF; Viner, S | 1 |
1 trial(s) available for transferrin and Follicular Thyroid Carcinoma
| Article | Year |
|---|---|
Recurrence after low-dose radioiodine ablation and recombinant human thyroid-stimulating hormone for differentiated thyroid cancer (HiLo): long-term results of an open-label, non-inferiority randomised controlled trial.
Topics: Adenocarcinoma, Follicular; Adenoma, Oxyphilic; Adolescent; Adult; Aged; Chemoradiotherapy, Adjuvant; Female; Humans; Iodine Radioisotopes; Kaplan-Meier Estimate; Male; Middle Aged; Neoplasm Recurrence, Local; Neoplasm Staging; Proportional Hazards Models; Radiotherapy Dosage; Thyroid Cancer, Papillary; Thyroid Neoplasms; Thyroidectomy; Thyrotropin Alfa; United Kingdom; Young Adult | 2019 |
7 other study(ies) available for transferrin and Follicular Thyroid Carcinoma
| Article | Year |
|---|---|
Utility of Stimulated Thyroglobulin in Reclassifying Low Risk Thyroid Cancer Patients' Following Thyroidectomy and Radioactive Iodine Ablation: A 7-Year Prospective Trial.
Topics: Adenocarcinoma, Follicular; Adolescent; Adult; Aged; Biomarkers, Tumor; Combined Modality Therapy; Female; Humans; Iodine Radioisotopes; Male; Middle Aged; Neoplasm Recurrence, Local; Prognosis; Prospective Studies; Thyroglobulin; Thyroid Neoplasms; Thyroidectomy; Thyrotropin Alfa; Young Adult | 2020 |
Unexpected symptoms after rhTSH administration due to occult thyroid carcinoma metastasis.
Topics: Adenocarcinoma, Follicular; Adenoma, Oxyphilic; Cervical Vertebrae; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Middle Aged; Neck Pain; Positron-Emission Tomography; Radiopharmaceuticals; Spinal Neoplasms; Thyroid Neoplasms; Thyrotropin Alfa | 2013 |
Stimulated thyroglobulin level at ablation in differentiated thyroid cancer: the impact of treatment preparation modalities and tumor burden.
Topics: Adenocarcinoma, Follicular; Adult; Aged; Carcinoma; Carcinoma, Papillary; Female; Humans; Iodine Radioisotopes; Male; Middle Aged; Neoplasm Recurrence, Local; Substance Withdrawal Syndrome; Thyroglobulin; Thyroid Cancer, Papillary; Thyroid Neoplasms; Thyrotropin; Thyrotropin Alfa; Thyroxine; Tomography, Emission-Computed, Single-Photon; Treatment Outcome; Triiodothyronine; Tumor Burden | 2014 |
The use of thyrogen in the treatment of differentiated thyroid carcinoma: an intraindividual comparison of clinical effects and implications of daily life.
Topics: Adenocarcinoma, Follicular; Adult; Carcinoma, Papillary; Female; Humans; Male; Middle Aged; Neoplasm Staging; Prospective Studies; Quality of Life; Thyroglobulin; Thyroid Neoplasms; Thyrotropin Alfa; Treatment Outcome | 2010 |
Recombinant human TSH increases uptake and effective half-life of radioiodine in thyroid hormone secreting metastases of follicular thyroid cancer.
Topics: Adenocarcinoma, Follicular; Combined Modality Therapy; Female; Half-Life; Humans; Iodine Radioisotopes; Middle Aged; Neoplasm Metastasis; Thyroid Hormones; Thyroid Neoplasms; Thyrotropin Alfa; Treatment Outcome; Up-Regulation | 2012 |
Undetectable sensitive serum thyroglobulin (<0.1 ng/ml) in 163 patients with follicular cell-derived thyroid cancer: results of rhTSH stimulation and neck ultrasonography and long-term biochemical and clinical follow-up.
Topics: Adenocarcinoma, Follicular; Adolescent; Adult; Aged; Aged, 80 and over; Female; Follow-Up Studies; Humans; Iodine Radioisotopes; Male; Middle Aged; Neck; Radiography, Thoracic; Retrospective Studies; Thyroglobulin; Thyroid Neoplasms; Thyrotropin Alfa; Tomography, X-Ray Computed; Ultrasonography | 2012 |
Increasing the yield of recombinant thyroid-stimulating hormone-stimulated 2-(18-fluoride)-flu-2-deoxy-D-glucose positron emission tomography-CT in patients with differentiated thyroid carcinoma.
Topics: Adenocarcinoma, Follicular; Adolescent; Adult; Aged; Aged, 80 and over; Carcinoma; Carcinoma, Papillary; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Multimodal Imaging; Neoplasm Recurrence, Local; Positron-Emission Tomography; Radiopharmaceuticals; Recombinant Proteins; Retrospective Studies; Sensitivity and Specificity; Thyroglobulin; Thyroid Cancer, Papillary; Thyroid Neoplasms; Thyrotropin Alfa; Tomography, X-Ray Computed; Young Adult | 2012 |